Microbot Medical Inc.
MBOT
$1.55
-$0.13-7.74%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 105.00K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 105.00K | -- | -- | -- | -- |
| Cost of Revenue | 103.00K | -- | -- | -- | -- |
| Gross Profit | 2.00K | -- | -- | -- | -- |
| SG&A Expenses | 3.03M | 5.46M | 2.69M | 1.61M | 1.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.43M | 4.14M | 3.86M | 3.72M | 3.02M |
| Operating Income | -4.32M | -4.14M | -3.86M | -3.72M | -3.02M |
| Income Before Tax | -3.67M | -3.46M | -3.58M | -3.50M | -2.60M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.67M | -3.46M | -3.58M | -3.50M | -2.60M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.67M | -3.46M | -3.58M | -3.50M | -2.60M |
| EBIT | -4.32M | -4.14M | -3.86M | -3.72M | -3.02M |
| EBITDA | -4.31M | -4.13M | -3.85M | -3.71M | -3.01M |
| EPS Basic | -0.05 | -0.05 | -0.07 | -0.10 | -0.08 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.05 | -0.06 | -0.06 |
| EPS Diluted | -0.05 | -0.05 | -0.07 | -0.10 | -0.08 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.05 | -0.06 | -0.06 |
| Average Basic Shares Outstanding | 67.16M | 67.31M | 48.10M | 36.49M | 31.09M |
| Average Diluted Shares Outstanding | 67.16M | 67.31M | 48.10M | 36.49M | 31.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |